Remove Article Remove Bipolar disorder Remove Genetics and mental health
article thumbnail

FDA Requires New Label Warning of Weight Loss Risk in Pediatric Patients Taking Extended-Release Stimulants for ADHD

Psychiatric Times

SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Healthcare professionals should monitor weight and growth in young patients on these medications and consider alternative treatments if adverse effects occur.

article thumbnail

NRx Pharmaceuticals Applies for FDA National Priority Voucher for Intravenous Ketamine (NRX-100)

Psychiatric Times

1 The newly announced CNPV pathway was introduced by FDA Commissioner Marty Makary, MD, MPH, on June 17, 2025, and is intended to expedite reviews for medications that address US public health priorities. The CNPV program, introduced by FDA Commissioner Marty Makary, aims to reduce review times to 1-2 months for eligible applications.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Psychiatric Pipeline in Review: Quarter 2, 2025

Psychiatric Times

Learn more in this exclusive article. Cobenfy failed to meet the primary endpoint in a phase 3 trial for schizophrenia, but showed numerical improvement, warranting further investigation. SHOW MORE What disease states are most prominently featured in recent research?

article thumbnail

New Guidelines on How to Accurately Convey ADHD Information

Mad in America

Unbalanced, for instance, in the sense that much emphasis is placed on brain and genetic studies that to this day have cost billions of dollars, while showing only very small associations—not providing any basis for biological screening. Genetic studies are also the cause of many misunderstandings.

article thumbnail

Who Do We Leave Behind When We Ignore the Body? Why Critical Neuroscientists and Mad Activists Must Work Together

Mad in America

A recent Neuroscience News article is titled “ Bipolar disorder can be detected with blood test. ” 1 This is one of many recent, oversimplified headlines that encourage us to think we are on the brink of discovering the next biomarker that will scientifically validate biomedical psychiatric disorders.

article thumbnail

Schizophrenia Test

Child Mind Intitute

Schizophrenia is a serious mental health condition that can cause people to lose touch with reality and see, hear, or believe things that arent real or true. Schizophrenia is a mental health disorder that affects an individuals ability to distinguish reality from fantasy. What is schizophrenia?

article thumbnail

Schizoaffective Disorder: Understanding the Incidence, Causes, Diagnosis, and Treatment

Now Psych

per cent of the population have schizoaffective disorder: its a lot less common than either major depression or bipolar disorder. Individuals with schizophrenia may have an increased risk for first-degree relatives for schizoaffective disorder, and vice-versa. What Causes Schizoaffective Disorder?